$QTTB

$8.71 +$0.26 (3.08%) Close

$QTTB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$QTTB Management Team

Mr. Mark Iwicki

Independent Chairman of the Board

Age 58

Compensation $414.5K USD

Sex Male

Mr. Lee Kalowski

President

Chief Financial Officer

Age 44

Compensation $2.854M USD

Sex Male

Ms. Jodie Morrison

Chief Executive Officer

Director

Age 49

Compensation $6.003M USD

Sex Female

Dr. Shelia Violette

Chief Scientific Officer

President of Research

Age 64

Compensation $716.2K USD

Sex Female

Dr. Adrien Sipos

Interim Chief Medical Officer

Age -

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Mark Iwicki Independent Chairman of the Board	58	$414.5K USD	Male
Mr. Lee Kalowski President Chief Financial Officer	44	$2.854M USD	Male
Ms. Jodie Morrison Chief Executive Officer Director	49	$6.003M USD	Female
Dr. Shelia Violette Chief Scientific Officer President of Research	64	$716.2K USD	Female
Dr. Adrien Sipos Interim Chief Medical Officer	-	-	Female

Board of Directors

From the proxy statement filed Apr 30, 2026

Directors

serving now

Independent

7 of 9

stated in the proxy

Average tenure

3.6 years

from year joined

CEO also chairs the board

Mark Iwicki

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Kathleen LaPorte	64	2024 2 years	Independent	Nominating and Corporate Governance	CERo Therapeutics Holdings, Inc.	$184,096
Jodie Morrison CEO	50	2024 2 years	Not independent	None stated	None stated	Paid as CEO
Arthur Tzianabos	63	2016 10 years	Not independent	Research and Development	Stoke Therapeutics, Inc.	Not stated
David Grayzel	58	2024 2 years	Independent	Research and Development	None stated	$166,024
Isaac Manke	49	2024 2 years	Independent	Compensation	None stated	Not stated
Diyong Xu	44	2024 2 years	Independent	Nominating and Corporate Governance	None stated	$163,237
Mark Iwicki Board chair	59	2024 2 years	Independent	Audit	Inhibikase Therapeutics, Inc.	$229,443
Bill Lundberg	62	2024 2 years	Independent	Compensation	None stated	$179,500
Mary Thistle	66	2018 8 years	Independent	Audit	Atkis Oncology, Inc.	$177,737

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$QTTB Management Team

Mr. Mark Iwicki

Mr. Lee Kalowski

Ms. Jodie Morrison

Dr. Shelia Violette

Dr. Adrien Sipos

Board of Directors

Related-party transactions

No related-party transactions disclosed